loadpatents
name:-0.03386402130127
name:-0.020589113235474
name:-0.01183819770813
Deng; Qiaolin Patent Filings

Deng; Qiaolin

Patent Applications and Registrations

Patent applications and USPTO patent grants for Deng; Qiaolin.The latest application filed is for "9-substituted amino triazolo quinazoline derivatives as adenosine receptor antagonists, pharmaceutical compositions and their use".

Company Profile
12.17.29
  • Deng; Qiaolin - Edison NJ
  • Deng; Qiaolin - Princeton NJ
  • DENG; Qiaolin - Rahway NJ US
  • DENG; Qiaolin - Kenilworth NJ US
  • DENG; Qiaolin - US
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
9-substituted Amino Triazolo Quinazoline Derivatives As Adenosine Receptor Antagonists, Pharmaceutical Compositions And Their Use
App 20220220117 - Larsen; Matthew A. ;   et al.
2022-07-14
3-(1H-pyrazol-4-yl)pyridine allosteric modulators of the M4 muscarinic acetylcholine receptor
Grant 11,339,156 - Acton, III , et al. May 24, 2
2022-05-24
9-substituted amino triazolo quinazoline derivatives as adenosine receptor antagonists, pharmaceutical compositions and their use
Grant 11,312,719 - Larsen , et al. April 26, 2
2022-04-26
Substituted Amino Triazolopyrimidine And Amino Triazolopyrazine Adenosine Receptor Antagonists, Pharmaceutical Compositions And Their Use
App 20220040184 - Brill; Zachary G. ;   et al.
2022-02-10
Substituted Amino Triazolopyrimidine And Amino Triazolopyrazine Adenosine Receptor Antagonists, Pharmaceutical Compositions And Their Use
App 20210395255 - Brill; Zachary G. ;   et al.
2021-12-23
3-(1h-pyrazol-4-yl)pyridine Allosteric Modulators Of The M4 Muscarinic Acetylcholine Receptor
App 20210380580 - ACTON, III; John J. ;   et al.
2021-12-09
3-(1H-pyrazol-4-yl)pyridine allosteric modulators of the M4 muscarinic acetylcholine receptor
Grant 11,149,036 - Acton, III , et al. October 19, 2
2021-10-19
9-substituted Amino Triazolo Quinazoline Derivatives As Adenosine Receptor Antagonists, Pharmaceutical Compositions And Their Use
App 20210107904 - Larsen; Matthew A. ;   et al.
2021-04-15
Long-acting Co-agonists Of The Glucagon And Glp-1 Receptors
App 20200392196 - Palani; Anandan ;   et al.
2020-12-17
Long-acting co-agonists of the glucagon and GLP-1 receptors
Grant 10,793,615 - Palani , et al. October 6, 2
2020-10-06
Long-acting Co-agonists Of The Glucagon And Glp-1 Receptors
App 20200270325 - Palani; Anandan ;   et al.
2020-08-27
3-(1h-pyrazol-4-yl)pyridine Allosteric Modulators Of The M4 Muscarinic Acetylcholine Receptor
App 20200207758 - ACTON, III; John J. ;   et al.
2020-07-02
Aminopyrazine compounds with A2A antagonist properties
Grant 10,472,347 - Kuang , et al. Nov
2019-11-12
Long-acting Co-agonists Of The Glucagon And Glp-1 Receptors
App 20190338008 - Palani; Anandan ;   et al.
2019-11-07
Co-agonists of the glucagon and GLP-1 receptors
Grant 10,413,593 - Bianchi , et al. Sept
2019-09-17
Insulin-incretin Conjugates
App 20190175744 - Palani; Anandan ;   et al.
2019-06-13
Aminopyrazine Compounds With A2a Antagonist Properties
App 20180327385 - KUANG; Rongze ;   et al.
2018-11-15
Heterobicyclo-substituted [1,2,4]triazolo[1,5-c]quinazolin-5-amine compounds with A2A anatagonist properties
Grant 10,011,615 - Ali , et al. July 3, 2
2018-07-03
Co-agonists Of The Glucagon And Glp-1 Receptors
App 20170360893 - Bianchi; Elisabetta ;   et al.
2017-12-21
Thiazole-substituted aminoheteroaryls as spleen tyrosine kinase inhibitors
Grant 9,745,295 - Anthony , et al. August 29, 2
2017-08-29
Heterobicyclo-substituted [1,2,4]triazolo[1,5-c]quinazolin-5-amine Compounds With A2a Antagonist Properties
App 20170197991 - Ali; Amjad ;   et al.
2017-07-13
Piperazine-substituted [1,2,4]triazolo[1,5-C]quinazolin-5-amine compounds with A.sub.2A antagonist properties
Grant 9,676,780 - Ali , et al. June 13, 2
2017-06-13
Piperazine-substituted [1,2,4]triazolo[1,5-c]quinazolin-5-amine Compounds With A2a Antagonist Properties
App 20160194330 - Ali; Amjad ;   et al.
2016-07-07
Co-agonists Of The Glucagon And Glp-1 Receptors
App 20160114000 - Bianchi; Elisabetta ;   et al.
2016-04-28
CETP Inhibitors
App 20160075724 - Ali; Amjad ;   et al.
2016-03-17
Thiazole-substituted Aminoheteroaryls As Spleen Tyrosine Kinase Inhibitors
App 20160060255 - Anthony; Neville J. ;   et al.
2016-03-03
Heterobicyclo-substituted [1,2,4]triazolo[1,5-c]quinazolin-5-amine Compounds With A2a Antagonist Properties
App 20150361098 - Ali; Amjad ;   et al.
2015-12-17
Cetp Inhibitors
App 20140221383 - Ali; Amjad ;   et al.
2014-08-07
CETP inhibitors
Grant 8,735,435 - Ali , et al. May 27, 2
2014-05-27
CETP inhibitors
Grant 8,193,365 - Ali , et al. June 5, 2
2012-06-05
Cetp Inhibitors
App 20100249024 - Ali; Amjad ;   et al.
2010-09-30
CETP inhibitors
Grant 7,737,295 - Ali , et al. June 15, 2
2010-06-15
Cetp Inhibitors
App 20100099716 - ALI; Amjad ;   et al.
2010-04-22
CETP inhibitors
Grant 7,652,049 - Ali , et al. January 26, 2
2010-01-26
Cetp Inhibitors
App 20080119476 - Ali; Amjad ;   et al.
2008-05-22
Niacin Receptor Agonists, Compositions Containing Such Compounds and Methods of Treatment
App 20070299101 - Colletti; Steven L. ;   et al.
2007-12-27
Cetp Inhibitors
App 20070225365 - Ali; Amjad ;   et al.
2007-09-27
CETP inhibitors
App 20060040999 - Ali; Amjad ;   et al.
2006-02-23

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed